Advertisement

Topics

Latest "Study on Hemodialysis: Illumination Effects" News Stories

05:07 EST 21st January 2019 | BioPortfolio

Here are the most relevant search results for "Study on Hemodialysis: Illumination Effects" found in our extensive news archives from over 250 global news sources.

More Information about Study on Hemodialysis: Illumination Effects on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Study on Hemodialysis: Illumination Effects for you to read. Along with our medical data and news we also list Study on Hemodialysis: Illumination Effects Clinical Trials, which are updated daily. BioPortfolio also has a large database of Study on Hemodialysis: Illumination Effects Companies for you to search.

Showing "Study Hemodialysis Illumination Effects" News Articles 1–25 of 21,000+

Monday 21st January 2019

Microbiome analysis company Bio-Me inks biomarker deal with one of the top 10 consumer healthcare companies worldwide

Bio-Me AS using proprietary custom-made microbiome test to analyze samples from NTNU’s  HUNT BioBank 21 January 2019: Oslo, Norway Bio-Me, a pioneer in rapid gut microbiome analysis, has entered into an agreement with one of the top 10 consumer healthcare companies worldwide using Bio-Me’s Precision Microbiome Profiling (PMP) platform and the HUNT BioBank to identify gut micr...


Vertex Announces European Commission Approval for ORKAMBI® (lumacaftor/ivacaftor) for Treatment of Children with Cystic Fibrosis Aged 2 to 5 Years Old with Most Common Form of the Disease

Lumacaftor/ivacaftor is the first and only approved medicine in Europe to treat the underlying cause of cystic fibrosis for approximately 1,500 children aged 2 to 5 with two copies of the F508del mutation Vertex Pharmaceuticals (Europe) Limited today announced that the European Commission has granted approval of the label extension for ORKAMBI®...

FDA clears Verily’s Study Watch for ECG

The FDA-approved Study Watch is a prescription-only device aimed to record, store, transfer and display single-channel ECG rhythms. It is suggested for use by healthcare professionals, adult patients The post FDA clears Verily’s Study Watch for ECG appeared first on Compelo Medical Devices.


Immunicum AB (publ) Announces Publication of Phase I/II Clinical Trial Results of Ilixadencel in Advanced Hepatocellular Carcinoma in Frontiers in Oncology

Press Release 21 January 2019 Immunicum AB (publ) Announces Publication of Phase  I/II Clinical Trial Results of Ilixadencel in Advanced Hepatocellular Carcinoma in Frontiers in Oncology Immunicum AB (publ; IMMU.ST) announced today that the final data analysis from the exploratory clinical study of ilixadencel in patients with advanced hepatocellular carcinoma (HCC) has been pub...

Dr. Kanani, Woodland Hills Dentist: Managing Risk Factors for Tooth Loss

The loss of teeth can affect more than just oral health, according to a March 7, 2013 Web MD article (“Tooth Loss Associated with Higher Risk for Heart Disease”). Woodland Hills dentist Dr. Kanani stresses the importance of prevention with regular cleanings, and possibly sedation for those who fear dental work. LOS ANGELES (PRWEB) January 21, 2019 Tooth loss can be caused by health risk facto...

Global Biosimilars Market Increasingly Lucrative Market Fueled by Constrained Payer Environment and Patent Expiries for BestSelling Biologics [Report Updated: 01012019] Prices from USD $2995

Global Biosimilars Market Increasingly Lucrative Market Fueled by Constrained Payer Environment and Patent Expiries for BestSelling BiologicsSummaryGBI Research's latest report: Biosimilars provides an indepth assessment of the current developments and trends in the global biosimilars market. This report also assesses the state of the biosimilar RD and commercial landscape through multilevel anal...

X-ray experiments reveal important mechanism behind parkinsonian disorders

A new X-ray study has revealed one of the key mechanisms behind certain familial-parkinsonian disorders. The study demonstrates in detail how poisoning with the metal manganese occurs inside a cell, leading to parkinsonian symptoms. It found that a specific genetic defect results in manganese accumu...

Sunday 20th January 2019

Study highlights need for reliable therapeutic targets for prevention, treatment of cardiovascular diseases

CVD (cardiovascular diseases) are proven to be the leading cause of deaths throughout the world. If statistics are reviewed, almost four out of five deaths are due to myocardial infarction or stroke.

Cancer survivors face significant hardships related to medical bills

(Wiley) New research indicates that cancer survivors carry greater financial burdens related to medical debt payments and bills compared with individuals without a cancer history, with the greatest hardships in younger survivors. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study also found that among privately insured survivors, those who enrolled ...

Asking patients about sexual orientation, gender identity

(Canadian Medical Association Journal) Patients are open to being asked about their sexual orientation and gender identity in primary care, which can help make health care more welcoming, although the stage should be set for these questions and they should include a range of options, found a study published in CMAJ (Canadian Medical Association Journal).

Vampire bats could hold key to new treatments; criminal activity hampers research

Vampire bats could hold the key to new treatments for a range of serious medical problems, but researchers have hit a snag accessing the specimens needed to advance their work. An international team led by The University of Queensland has found a new class of blood pressure-regulating peptides in the venom of the common vampire bat (Diphylla ecaudata). The peptides could help revolutionise treat...

Study shows hereditary hemochromatosis behind many cancers and joint diseases

A British study has found that “stealth disease”, also known as hemochromatosis, could be the reason behind several disease conditions including cancers and joint diseases.

Immune Cell Study Opens Door to Better Understanding of Hypertension: http://ow.ly/ZXA530nlLJx pic.twitter.com/TkJ3V2NP4A

Immune Cell Study Opens Door to Better Understanding of Hypertension: http://ow.ly/ZXA530nlLJx  pic.twitter.com/TkJ3V2NP4A

Which affects health more — DNA code or ZIP code?

The study confirms that genes and environment often work together to influence health.

Pioneering brain study reveals ‘software’ differences between humans and monkeys

Quick Take: An evaluation of the effects of lowering blood alcohol concentration limits for drivers on the rates of road traffic accidents and alcohol consumption: a natural experiment

Individuals that drive while under the influence of alcohol are at an increased risk of being involved in traffic accidents, contributing to the morbidity and mortality of the individual and others. In this observational natural experiment in Scotland, the effects of lowering the legal driving limit from a blood alcohol content (BAC) of 0.08 grams […] Source: 2 Minute Medicine

Saturday 19th January 2019

Medical News Today: Central obesity linked to brain shrinkage

A recent study has linked central obesity to shrinkage in certain parts of the brain. The question now is whether obesity causes brain shrinkage.

Lilly: Phase 3 Soft Tissue Sarcoma Study Fails To Meet Primary Endpoints

INDIANAPOLIS (dpa-AFX) - Eli Lilly and Company (LLY) said that a late-stage trial of a treatment for sarcoma did not meet the primary endpoints. It is suspending promotion of lartruvo. It expects ...

Ecological benefits of part-night lighting revealed

(Newcastle University) Study shows there is no difference in pollination success between part-night lighting and full darkness, highlighting the ecological benefit of switching off our street lights even for short periods in the night.

Presentation of Clearside Biomedical’s Extension Study of PEACHTREE for XIPERE™ Exhibits Durability Following Second Dose

ALPHARETTA, Ga., Jan. 20, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye diseases, announced today that data from MAGNOLIA, an extension study of PEACHTREE, its pivotal Phase 3 trial of XIPERE™ (formerly “suprachoroidal CLS-TA”) in patients with ...

Pacira Pharma phase 4 study of Exparel in patients undergoing C─section achieves primary endpoint with significant reductions in opioid consumption

Pacira Pharmaceuticals, announced that its phase 4 study of Exparel (bupivacaine liposome injectable suspension) in patients undergoing Cesarean section (C─section) achieved its primary endpoint with a

In utero dioxin exposure and cardiometabolic risk in the Seveso Second Generation Study

Quick Take: Use of Hormone Replacement Therapy and Risk of Venous Thromboembolism: Nested Case-Control Studies Using the QResearch and CPRD Databases

Hormone replacement therapy (HRT), often prescribed to women during menopause, has been shown to increase the risk for venous thromboembolism (VTE). However, the effects of different types of HRT preparations on the risk of VTE have not been thoroughly investigated. This case-control study enrolled women between the ages of 40 and 79 years living in […] Source:

Analysis of Cdcs1 colitogenic effects in the hematopoietic compartment reveals distinct microbiome interaction and a new subcongenic interval active in T cells

Early Signs for Scleroderma Renal Crisis

(MedPage Today) -- New study lays out range of factors that can increase patients' risk


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks